Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct:43:8-15.
doi: 10.1016/j.cytogfr.2018.08.004. Epub 2018 Aug 29.

The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators

Stephanie Binder  1 , Michela Luciano  1 , Jutta Horejs-Hoeck  2
Affiliations
Review

The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators

Stephanie Binder et al. Cytokine Growth Factor Rev. 2018 Oct.

Abstract

Cytokines exert profound effects on the progression of hematopoietic malignancies such as acute myeloid leukemia (AML). Critical roles of cytokines in the context of inflammation have gained special interest. While pro-inflammatory mediators such as IL-1β, TNF-α and IL-6 tend to increase AML aggressiveness, anti-inflammatory mediators such as TGF-β and IL-10 appear to impede AML progression. Dysregulation of the complex interactions between pro- and anti-inflammatory cytokines in AML may create a pro-tumorigenic microenvironment with effects on leukemic cell proliferation, survival and drug-resistance. This article summarizes current knowledge about the functions of pro- and anti-inflammatory cytokines in AML, their modes of action, and therapeutic interventions with potential to improve clinical outcomes for AML patients.

Keywords: Acute myeloid leukemia (AML); IL-10; IL-1Ra; IL-1β; IL-35; IL-6; TGFβ.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

LinkOut - more resources